As of 2025-07-03, the Intrinsic Value of Kaleido Biosciences Inc (KLDO) is -30,716.65 USD. This KLDO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.29 USD, the upside of Kaleido Biosciences Inc is -10,592,048.40%.
Based on its market price of 0.29 USD and our intrinsic valuation, Kaleido Biosciences Inc (KLDO) is overvalued by 10,592,048.40%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -30,716.65 - -30,716.65 | -30,716.65 | -10,592,048.40% |
| P/E | (118,443.32) - (113,160.06) | (118,719.77) | -40937951.2% |
| DDM - Stable | (34.89) - (64.60) | (49.75) | -17254.3% |
| DDM - Multi | 0.00 - 0.00 | 0.00 | -100.0% |
| Market Cap (mil) | 0.00 |
| Beta | -647.47 |
| Outstanding shares (mil) | 0.01 |
| Enterprise Value (mil) | -16.78 |
| Market risk premium | 4.60% |
| Cost of Equity | 10,445.40% |
| Cost of Debt | 5.00% |
| WACC | 5.72% |